GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Total Assets

Caplin Point Laboratories (BOM:524742) Total Assets : ₹29,242 Mil (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Total Assets?

Caplin Point Laboratories's Total Assets for the quarter that ended in Sep. 2024 was ₹29,242 Mil.

Warning Sign:

If a company builds assets at 26.9% a year, faster than its revenue growth rate of 20.5% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Caplin Point Laboratories's average Total Assets Growth Rate was 21.70% per year. During the past 3 years, the average Total Assets Growth Rate was 27.70% per year. During the past 5 years, the average Total Assets Growth Rate was 26.90% per year. During the past 10 years, the average Total Assets Growth Rate was 30.70% per year.

During the past 13 years, Caplin Point Laboratories's highest 3-Year average Total Assets Growth Rate was 47.60%. The lowest was 4.90%. And the median was 27.90%.

Total Assets is connected with ROA %. Caplin Point Laboratories's annualized ROA % for the quarter that ended in Sep. 2024 was 17.89%. Total Assets is also linked to Revenue through Asset Turnover. Caplin Point Laboratories's Asset Turnover for the quarter that ended in Sep. 2024 was 0.17.


Caplin Point Laboratories Total Assets Historical Data

The historical data trend for Caplin Point Laboratories's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Total Assets Chart

Caplin Point Laboratories Annual Data
Trend Jun15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,257.57 13,636.10 17,363.20 21,914.00 26,981.20

Caplin Point Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,128.40 - 26,981.20 - 29,242.20

Caplin Point Laboratories Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Caplin Point Laboratories's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=23468.3+3512.9
=26,981

Caplin Point Laboratories's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=25746+3496.2
=29,242

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caplin Point Laboratories  (BOM:524742) Total Assets Explanation

Total Assets is connected with ROA %.

Caplin Point Laboratories's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=5232/( (0+29242.2)/ 1 )
=5232/29242.2
=17.89 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Caplin Point Laboratories's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=4831/( (0+29242.2)/ 1 )
=4831/29242.2
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Caplin Point Laboratories Total Assets Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.

Caplin Point Laboratories Headlines

No Headlines